C07D 235/30
Nitrogen atoms not forming part of a nitro radical
C07D235/30 (Nitrogen atoms not forming part of a nitro radical) appears on 680 US grants and 575 published applications in this corpus.
Search patents in C07D- Granted patents
- 680
- Published applications
- 575
- Assignees
- 374
- Inventors
- 2,088
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 26 | 0 |
| 1977 | 17 | 0 |
| 1978 | 14 | 0 |
| 1979 | 15 | 0 |
| 1980 | 10 | 0 |
| 1981 | 16 | 0 |
| 1982 | 8 | 0 |
| 1983 | 6 | 0 |
| 1984 | 10 | 0 |
| 1985 | 11 | 0 |
| 1986 | 9 | 0 |
| 1987 | 5 | 0 |
| 1988 | 4 | 0 |
| 1989 | 5 | 0 |
| 1990 | 7 | 0 |
| 1991 | 2 | 0 |
| 1992 | 5 | 0 |
| 1993 | 7 | 0 |
| 1994 | 7 | 0 |
| 1995 | 9 | 0 |
| 1996 | 9 | 0 |
| 1997 | 11 | 0 |
| 1998 | 12 | 0 |
| 1999 | 13 | 0 |
| 2000 | 11 | 0 |
| 2001 | 17 | 6 |
| 2002 | 26 | 29 |
| 2003 | 20 | 21 |
| 2004 | 15 | 42 |
| 2005 | 9 | 28 |
| 2006 | 22 | 16 |
| 2007 | 11 | 29 |
| 2008 | 14 | 20 |
| 2009 | 14 | 24 |
| 2010 | 12 | 24 |
| 2011 | 22 | 25 |
| 2012 | 18 | 18 |
| 2013 | 16 | 20 |
| 2014 | 18 | 17 |
| 2015 | 22 | 15 |
| 2016 | 12 | 22 |
| 2017 | 16 | 24 |
| 2018 | 16 | 28 |
| 2019 | 27 | 23 |
| 2020 | 23 | 33 |
| 2021 | 21 | 22 |
| 2022 | 17 | 17 |
| 2023 | 14 | 24 |
| 2024 | 12 | 18 |
| 2025 | 13 | 17 |
| 2026 | 4 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Small molecule inhibitors of SLC15A4 with anti-inflammatory activity1 Sep 2026US 12,723,039 B2The Scripps Research Institute
- Aryl receptor modulators and methods of making and using the same17 Mar 2026US 12,577,256 B2Nogra Pharma Limited
- Methods and compositions for targeting Tregs using CCR8 inhibitors17 Feb 2026US 12,552,753 B2Nanjing Immunophage Biomedical Co., Ltd.
- Substituted benzimidazole derivative and use thereof13 Jan 2026US 12,522,569 B2Chengdu FANXI Biopharma Co., Ltd.
- Imidazopyridine derivatives and aza-imidazopyridine derivatives as Janus kinase 2 inhibitors and uses thereof30 Dec 2025US 12,509,455 B2Dana-Farber Cancer Institute, Inc.
- Bicyclic inhibitors of cbx chromodomains8 Oct 2026US 2026/0308130 A1Icahn School of Medicine at Mount Sinai
- Diamidine analogs for anti-inflammatory use10 Sep 2026US 2026/0263426 A1Montdorex Inc.
- Fabk inhibitor compositions10 Sep 2026US 2026/0265242 A1The Texas A&M University System
- Compounds, compositions and methods of use to treat hypoparathyroidism and osteoporosis3 Sep 2026US 2026/0258007 A1Septerna, Inc.
- Cdk8/19 dual inhibitors and methods of use thereof20 Aug 2026US 2026/0240861 A1Insilico Medicine IP Limited
Most cited
By later US patents
- Heterocyclic compounds useful as inhibitors of tyrosine kinases202US 6,506,769 B2Boehringer Ingelheim Pharmaceuticals, Inc. · 2003
- Heterocyclic compounds useful as inhibitors of tyrosine kinases190US 6,770,639 B2Boehringer Ingelheim Pharmaceuticals, Inc. · 2004
- Compounds enhancing antitumor activity of other cytotoxic agents116US 6,130,217 APfizer Inc. · 2000
- Substituted benzimidazole compounds95US 7,138,420 B2Boehringer Ingelheim Pharmaceuticals, Inc. · 2006
- Aromatic heterocyclic compounds and their use as anti-inflammatory agents91US 6,080,763 ABoehringer Ingelheim Pharmaceuticals, Inc. · 2000